Latest News
European private equity firm Bridgepoint, via Star Healthcare, has made a public tender offer to purchase all of the issued and outstanding shares in Terveystalo Healthcare not owned by
Northern Lights Ventures has acquired an equity stake in Michigan-based investment management firm Seizert Capital Partners.
While the terms were not disclosed, management will retain majority interest in the firm.
Established in 2000, Seizert offers three long-only equity products: Large Cap Core, Mid Cap Core, and Large Cap Value, as well as a long/short equity hedge fund. Each strategy has at least a five-year track record, and performance has been strong relative to their respective benchmarks.
Seizert is led by its three founding partners – chief executive Gerry Seizert, president Ed Eberle, and chief operating officer Chuck Schmidt
Leeds Equity Partners, a New York-based private equity firm focused on the education, training and information industries, has promoted two of its professionals.
Basel-based BioMedPartners has announced the first closing of BioMedInvest II, the firm’s second venture capital fund, at CHF95m.
The astute observer might have noticed a clue last week about the direction of hedge funds in the coming months, with the announcement that Hong Kong-based asset manager Sun Hung Kai Finan
Octopus Ventures, a specialist investor in early-stage and expanding companies, has invested GBP2m in Zoopla.co.uk, an online property information service and community website.
Job security concerns are widespread in the US private equity and venture capital industries due to difficulties in raising future rounds of capital, according to a survey by JobSearchD
Millennium Private Equity, the private equity arm of Dubai-based investment bank Millennium Finance Corporation, has announced an investment of AED92m in Kuwait Energy Company, one of t
Private equity firm the Carlyle Group has named Ian Jackson as a director of Carlyle Strategic Partners, Carlyle’s global distressed and corporate opportunities group that invests in de
Zurich-based business development, finance and strategy consultancy HS LifeSciences has established an investment fund called QureInvest, dedicated to new start-up biotech companies.
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm